Predictive Modeling of the Human Hepatoma (Huh-7d12) Cancer Line of a Series of Bis- (5-Arylidene-Rhodanine-3-Yl) Diamine

Asian Journal of Chemical Sciences
doi 10.9734/ajocs/2019/v6i218993
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Sciencedomain International

Related search

Synthesis of New N,n′-Bis[1-Aryl-3-(Piperidine-1-Yl)propylidene]hydrazine Dihydrochlorides and Evaluation of Their Cytotoxicity Against Human Hepatoma and Breast Cancer Cells

Journal of Enzyme Inhibition and Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2013English

The Design and Cytotoxic Evaluation of Some 1-Aryl-3-Isopropylamino-1-Propanone Hydrochlorides Towards Human Huh-7 Hepatoma Cells

Archiv der Pharmazie
Drug DiscoveryPharmaceutical Science
2011English

A Third Polymorph ofN,N′-bis(pyridin-2-yl)benzene-1,4-diamine

Acta Crystallographica Section E Structure Reports Online
2011English

Drug Transporter Expression and Activity in Human Hepatoma HuH-7 Cells

Pharmaceutics
Pharmaceutical Science
2016English

Hexaaquazinc(II) Dinitrate Bis[5-(Pyridinium-3-Yl)tetrazol-1-Ide]

Acta Crystallographica Section E: Crystallographic Communications
Materials ScienceChemistryCondensed Matter Physics
2018English

Preparation of Bis- And Tris(diamine)chromium(III) Complexes via Dimethyl Sulfoxide and Dimethylformamide Complexes. The Novel Series of Cis-Bis(trimethylene-Diamine)- And Cis-Bis[(-)Trans-1,2-Cyclohexane-Diamine]chromium(III) Complexes.

Acta Chemica Scandinavica
1970English

Concise Route to a Series of Novel 3-(Tetrazol-5-Yl)quinoxalin-2(1h)-Ones

Tetrahedron Letters
Organic ChemistryBiochemistryDrug Discovery
2012English

N,n′-Bis(3-Phenylallylidene)biphenyl-2,2′-Diamine

Acta Crystallographica Section E Structure Reports Online
2009English

2-[2-(1h-Imidazol-3-Ium-5-Yl)ethyl]-3-(Pyridin-2-Yl)-2h-Imidazo[1,5-A]pyridin-4-Ium Bis(perchlorate)

Acta Crystallographica Section E Structure Reports Online
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy